Micro-RNA Expression Profiles in Localised Prostate Cancer
NCT03338712 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-12-12
Summary
Recurrence free survival The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.
Conditions
- Prostate Cancer
- Radical Prostatectomy
Sponsors & Collaborators
-
Wuerzburg University Hospital
lead OTHER
Eligibility
- Min Age
- 35 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-01
- Primary Completion
- 2016-04-01
- Completion
- 2016-04-01
More Related Trials
-
Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
NCT06657131 ·Status: RECRUITING
-
Early and Accurate Detection of Prostate Cancer in General Practice
NCT03431753 ·Status: UNKNOWN ·Phase: NA
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence
NCT04645810 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
NCT04742361 ·Status: COMPLETED ·Phase: PHASE3
-
PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma
NCT00427817 ·Status: COMPLETED
-
PSMA-RLT in Biochemically Recurrent PCa
NCT06220188 ·Status: RECRUITING ·Phase: PHASE2
-
Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer
NCT06468332 ·Status: RECRUITING
-
Prospective Prostate Cancer and Patient-reported Outcomes Registry
NCT04694924 ·Status: RECRUITING
-
Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau
NCT06637267 ·Status: RECRUITING
-
HRR Prevalence in LatAm PROSPECT Study
NCT04962880 ·Status: COMPLETED
-
Focal Therapy for Localized Prostate Cancer
NCT03970863 ·Status: WITHDRAWN
-
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
NCT04404894 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
NCT06122584 ·Status: RECRUITING ·Phase: PHASE3
-
Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
NCT04686188 ·Status: UNKNOWN
-
Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney
NCT06214000 ·Status: COMPLETED
-
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
NCT05384002 ·Status: COMPLETED
-
Local Treatment With RP for Newly-diagnosed mPCa
NCT02138721 ·Status: RECRUITING ·Phase: NA
-
Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy
NCT04773821 ·Status: UNKNOWN ·Phase: NA
-
Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer
NCT01615965 ·Status: UNKNOWN ·Phase: NA
-
Investigation of the Diagnostic Role of miRNAs in PCa and BPH
NCT06726070 ·Status: COMPLETED
-
Familial Prostate Cancer
NCT00001377 ·Status: COMPLETED
-
Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma
NCT02181192 ·Status: UNKNOWN ·Phase: NA
-
Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer
NCT03122470 ·Status: WITHDRAWN ·Phase: NA
-
Ga-68-PSMA-11 in High-risk Prostate Cancer
NCT03362359 ·Status: COMPLETED ·Phase: PHASE1/PHASE2